Risk factors in malignant transformation of gastric epithelial neoplasia categorized by the revised Vienna classifi cation: Endoscopic, pathological, and immunophenotypic features

Gastric Cancer

Volumn 13, Issue 2, 2010, Pages 123-130

  Jung, Sung Hoon ^a   Chung, Woo Chul ^a   Lee, Kang Moon ^a   Paik, Chang Nyol ^a   Jung, Ji Han ^a   Lee, Min Kyoung ^b   Lee, Yun Kyung ^c   Chung, In Sik ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Samsung Medical Center   (South Korea)

Author keywords

Gastric epithelial neoplasia; MUC6; Vienna classification

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; MUCIN 2; MUCIN 5AC; MUCIN 6; TRANSCRIPTION FACTOR RUNX3; MUC6 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOSCOPY; FEMALE; GASTRIC EPITHELIAL NEOPLASIA; GENE EXPRESSION; GENE FUNCTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; STOMACH TUMOR; STOMACH ULCER; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; VIENNA CLASSIFICATION; ADENOCARCINOMA; ADENOMA; AGED; CLASSIFICATION; GASTROSCOPY; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PRECANCER; STOMACH MUCOSA;

ADENOCARCINOMA; ADENOMA; AGED; FEMALE; GASTRIC MUCOSA; GASTROSCOPY; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; MUCIN-6; MULTIVARIATE ANALYSIS; PRECANCEROUS CONDITIONS; RISK FACTORS; STOMACH NEOPLASMS;

EID: 78049274899     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-010-0550-7     Document Type: Article

References (49)

1. Kamiya T, Morishita T, Asakura H, Miura S, Munakata Y, Tsuchiya M. Long-term follow-up study on gastric adenoma and its relation to gastric protruded carcinoma. Cancer 1982;50:2496-2503
2. Orlowska J, Jarosz D, Pachlewski J, Butruk E. Malignant transformation of benign epithelial gastric polyps. Am J Gastroenterol 1995;90:2152-2159
3. Schlemper RJ, Kato Y, Stolte M. Well-differentiated adenocarcinoma or dysplasia of the gastric epithelium: Rationale for a new classification system. Verh Dtsch Ges Pathol 1999;83:62-70.
4. Stolte M. Diagnosis of gastric carcinoma: Japanese fairy tales or Western deficiency? Virchows Arch 1999;434:279-280
5. Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-255
6. Stolte M. The new Vienna classification of epithelial neoplasia of the gastrointestinal tract: Advantages and disadvantages. Virchows Arch 2003;442:99-106.
7. Lauwers GY, Riddell RH. Gastric epithelial dysplasia. Gut 1999; 45:784-790
8. Takenawa H, Kurosaki M, Enomoto N, Miyasaka Y, Kanazawa N, Sakamoto N, et al. Differential gene-expression profi les associated with gastric adenoma. Br J Cancer 2004;90:216-223
9. Park SY, Jeon SW, Jung MK, Cho CM, Tak WY, Kweon YO, et al. Long-term follow-up study of gastric intraepithelial neoplasias: Progression from low-grade dysplasia to invasive carcinoma. Eur J Gastroenterol Hepatol 2008;20:966-970
10. Tsukashita S, Kushima R, Bamba M, Sugihara H, Hattori T. MUC gene expression and histogenesis of adenocarcinoma of the stomach. Int J Cancer 2001;94:166-170
11. Minematsu H, Saito Y, Kakinoki R, Andoh A, Kushima R, Fujiyama Y. Evaluation of mucin expression patterns in gastric borderline (group III) lesions. J Gastroenterol 2006;41:547-553
12. Lund AH, van Lohuizen M. RUNX: A trilogy of cancer genes. Cancer Cell 2002;1:213-215
13. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002;109:113-124
14. Chi XZ, Yang JO, Lee KY, Ito K, Sakakura C, Li QL, et al. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/ Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD. Mol Cell Biol 2005;25:8097-8107
15. Dixon MF, Genta RM, Yardley JH, Correa P. Classifi cation and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-1181
16. Kocer B, Soran A, Kiyak G, Erdogan S, Eroglu A, Bozkurt B, et al. Prognostic significance of mucin expression in gastric carcinoma. Dig Dis Sci 2004;49:954-964
17. Tajima Y, Shimoda T, Nakanishi Y, Yokoyama N, Tanaka T, Shimizu K, et al. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: Immunohistochemical analysis of 136 lesions. Oncology 2001;61:212-220
18. Wakatsuki K, Yamada Y, Narikiyo M, Ueno M, Takayama T, Tamaki H, et al. Clinicopathological and prognostic significance of mucin phenotype in gastric cancer. J Surg Oncol 2008;98: 124-129
19. Shiroshita H, Watanabe H, Ajioka Y, Watanabe G, Nishikura K, Kitano S. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains. Pathol Int 2004;54:311-321
20. Schlemper RJ, Kato Y, Stolte M. Review of histological classifications of gastrointestinal epithelial neoplasia: Differences in diagnosis of early carcinomas between Japanese and Western pathologists. J Gastroenterol 2001;36:445-456
21. Sung HY, Cheung DY, Cho SH, Kim JI, Park SH, Han JY, et al. Polyps in the gastrointestinal tract: Discrepancy between endoscopic forceps biopsies and resected specimens. Eur J Gastroenterol Hepatol 2009;21:190-195
22. Yoon WJ, Lee DH, Jung YJ, Jeong JB, Kim JW, Kim BG, et al. Histologic characteristics of gastric polyps in Korea: Emphasis on discrepancy between endoscopic forceps biopsy and endoscopic mucosal resection specimen. World J Gastroenterol 2006;12: 4029-4032
23. Szalóki T, Tóth V, Tiszlavicz L, Czakó L. Flat gastric polyps: Results of forceps biopsy, endoscopic mucosal resection, and long-term follow-up. Scand J Gastroenterol 2006;41:1105-1109
24. Park DI, Rhee PL, Kim JE, Hyun JG, Kim YH, Son HJ, et al. Risk factors suggesting malignant transformation of gastric adenoma: Univariate and multivariate analysis. Endoscopy 2001;33:501-506
25. Tabata H, Fuchigami T, Kobayashi H, Sakai Y, Nakanishi M, Tomioka K, et al. Difference in degree of mucosal atrophy between elevated and depressed types of gastric epithelial tumors. Scand J Gastroenterol 2001;36:1134-1140
26. Vieth M, Stolte M. Elevated risk for gastric adenocarcinoma can be predicted from histomorphology. World J Gastroenterol 2006; 12:6109-6114
27. Jung MK, Jeon SW, Park SY, Cho CM, Tak WY, Kweon YO, et al. Endoscopic characteristics of gastric adenomas suggesting carcinomatous transformation. Surg Endosc 2008;22:2705-2711
28. Carraway KL, Fregien N. Mucin structure and function: Insights from molecular biology. Trends Glycosci Glycotechnol 1995;33: 31-44.
29. Ho SB, Niehans GA, Lyftogt C, Yan PS, Cherwitz DL, Gum ET, et al. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res 1993;53:641-651
30. Reis CA, David L, Correa P, Carneiro F, de Bolós C, Garcia E, et al. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 1999;59:1003-1007
31. Morgenstern S, Koren R, Moss SF, Fraser G, Okon E, Niv Y. Does Helicobacter pylori affect gastric mucin expression? Relationship between gastric antral mucin expression and H. pylori colonization. Eur J Gastroenterol Hepatol 2001;13:19-23. (Pubitemid 32099563)
32. Kang HM, Kim N, Park YS, Hwang JH, Kim JW, Jeong SH, et al. Effects of Helicobacter pylori infection on gastric mucin expression. J Clin Gastroenterol 2008;42:29-35.
33. Yoshikawa A, Inada Ki K, Yamachika T, Shimizu N, Kaminishi M, Tatematsu M. Phenotypic shift in human differentiated gastric cancers from gastric to intestinal epithelial cell type during disease progression. Gastric Cancer 1998;1:134-141
34. Tatematsu M, Ichinose M, Miki K, Hasegawa R, Kato T, Ito N. Gastric and intestinal phenotypic expression of human stomach cancers as revealed by pepsinogen immunohistochemistry and mucin histochemistry. Acta Pathol Jpn 1990;40:494-504.
35. Endoh Y, Sakata K, Tamura G, Ohmura K, Ajioka Y, Watanabe H, et al. Cellular phenotypes of differentiated type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways. J Pathol 2000;191:257-263
36. Sakai H, Jinawath A, Yamaoka S, Yuasa Y. Upregulation of MUC6 mucin gene expression by NFkappaB and Sp factors. Biochem Biophys Res Commun 2005;333:1254-1260
37. Owens SR, Chiosea SI, Kuan SF. Selective expression of gastric mucin MUC6 in colonic sessile serrated adenoma but not in hyperplastic polyp aids in morphological diagnosis of serrated polyps. Mod Pathol 2008;21:660-669
38. Zheng HC, Li XH, Hara T, Masuda S, Yang XH, Guan YF, et al. Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas. Virchows Arch 2008; 452:525-534
39. Meining A, Bayerdorffer E, Muller P, Miehlke S, Lehn N, Holzel D, et al. Gastric carcinoma risk index in patients infected with Helicobacter pylori. Virchows Arch 1998;432:311-314
40. Miehlke S, Hackelsberger A, Meining A, Hatz R, Lehn N, Malfertheiner P, et al. Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer 1998;78:263-266
41. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988;48:3554-3560
42. Meining A, Stolte M, Hatz R, Lehn N, Miehlke S, Morgner A, et al. Differing degree and distribution of gastritis in Helicobacter pylori-associated diseases. Virchows Arch 1997;431:11-15
43. Matsukura N, Suzuki K, Kawachi T, Aoyagi M, Sugimura T, Kitaoka H, et al. Distribution of marker enzymes and mucin in intestinal metaplasia in human stomach and relation to complete and incomplete types of intestinal metaplasia to minute gastric carcinomas. J Natl Cancer Inst 1980;65:231-240
44. Morson BC. Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa. Br J Cancer 1955;9:377-385
45. Filipe MI, Munoz N, Matko I, Kato I, Pompe-Kirn V, Jutersek A, et al. Intestinal metaplasia types and the risk of gastric cancer: A cohort study in Slovenia. Int J Cancer 1994;57:324-329
46. You WC, Blot WJ, Li JY, Chang YS, Jin ML, Kneller R, et al. Precancerous gastric lesions in a population at high risk of stomach cancer. Cancer Res 1993;53:1317-1321
47. Nardone G, Rocco A, Staibano S, Mezza E, Autiero G, Compare D, et al. Diagnostic accuracy of the serum profi le of gastric mucosa in relation to histological and morphometric diagnosis of atrophy. Aliment Pharmacol Ther 2005;22:1139-1146
48. Bae SC, Takahashi E, Zhang YW, Ogawa E, Shigesada K, Namba Y, et al. Cloning, mapping and expression of PEBP2 alpha C, a third gene encoding the mammalian Runt domain. Gene 1995; 159:245-248
49. Osaki M, Moriyama M, Adachi K, Nakada C, Takeda A, Inoue Y, et al. Expression of RUNX3 protein in human gastric mucosa, intestinal metaplasia and carcinoma. Eur J Clin Invest 2004;34: 605-612